Authors:
SEEGER TF
SEYMOUR PA
SCHMIDT AW
ZORN SH
SCHULZ DW
LEBEL LA
MCLEAN S
GUANOWSKY V
HOWARD HR
LOWE JA
HEYM J
Citation: Tf. Seeger et al., ZIPRASIDONE (CP-88,059) - A NEW ANTIPSYCHOTIC WITH COMBINED DOPAMINE AND SEROTONIN RECEPTOR ANTAGONIST ACTIVITY, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 101-113
Citation: Bk. Koe et La. Lebel, EFFECTS OF SEROTONINERGIC AGENTS ON DOWN-REGULATION OF BETA-ADRENOCEPTORS BY THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR SERTRALINE, Archives internationales de pharmacodynamie et de therapie, 329(2), 1995, pp. 231-244
Authors:
LEBEL LA
NOWAKOWSKI JT
MACOR JE
FOX CB
KOE BK
Citation: La. Lebel et al., DOPAMINE UPTAKE INHIBITORY ACTIVITY OF NOVEL TRYPTAMINE 5-HT, RECEPTOR LIGANDS, Drug development research, 33(4), 1994, pp. 413-421
Authors:
MACOR JE
BLANK DH
FOX CB
LEBEL LA
NEWMAN ME
POST RJ
RYAN K
SCHMIDT AW
SCHULZ DW
KOE BK
Citation: Je. Macor et al., 5-[(3-NITROPYRID-2-YL)AMINO]INDOLES - NOVEL SEROTONIN AGONISTS WITH SELECTIVITY FOR THE 5-HT1D RECEPTOR - VARIATION OF THE C3 SUBSTITUENT ON THE INDOLE TEMPLATE LEADS TO INCREASED 5-HT1D RECEPTOR SELECTIVITY, Journal of medicinal chemistry, 37(16), 1994, pp. 2509-2512